{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:26:25Z","timestamp":1783470385671,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22Y11910300"],"award-info":[{"award-number":["22Y11910300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24CL2900704"],"award-info":[{"award-number":["24CL2900704"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371024"],"award-info":[{"award-number":["82371024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtos.2025.07.009","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:40:54Z","timestamp":1753832454000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tear lymphotoxin-alpha deficiency is associated with conjunctival epitheliopathy in patients with dry eye disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Yun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"A","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2025.07.009_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/aos.13436","article-title":"Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting","volume":"96","author":"Baudouin","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"14","key":"10.1016\/j.jtos.2025.07.009_bib5","doi-asserted-by":"crossref","first-page":"Des157","DOI":"10.1167\/iovs.17-23756","article-title":"The ocular surface glycocalyx and its alteration in dry eye disease: a review","volume":"59","author":"Uchino","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3376","article-title":"Lymphotoxin \u03b1 revisited: general features and implications in rheumatoid arthritis","volume":"13","author":"Calmon-Hamaty","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14728222.2019.1586886","article-title":"Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target","volume":"23","author":"Medler","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"34","key":"10.1016\/j.jtos.2025.07.009_bib9","doi-asserted-by":"crossref","first-page":"17045","DOI":"10.1073\/pnas.1902091116","article-title":"TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes","volume":"116","author":"Fischer","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00007890-199910150-00008","article-title":"Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation","volume":"68","author":"Yamada","year":"1999","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. Cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib12","article-title":"Large scale, prospective, multicenter, clinical evaluation of point-of-care lymphotoxin alpha (LTA) test in dry eye disease","volume":"61","author":"Lin","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2025.07.009_bib13","article-title":"Altered lymphotoxin alpha (LTA) level in tear fluid, measured with a POCT test, in dry eye patients","volume":"59","author":"Huang","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2025.07.009_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113548","article-title":"Interferons and dry eye in sj\u00f6gren's syndrome","volume":"19","author":"Ogawa","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.07.009_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12886-022-02251-y","article-title":"Ophthalmic manifestations are associated with reduced tear lymphotoxin-\u03b1 levels in chronic ocular graft-versus-host disease","volume":"22","author":"Ma","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2025.07.009_bib16","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.4049\/jimmunol.1001520","article-title":"A role for lymphotoxin in primary Sjogren's disease","volume":"185","author":"Shen","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2025.07.009_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/annrheumdis-2011-200446","article-title":"Association between genetic variants in the tumour necrosis factor\/lymphotoxin \u03b1\/lymphotoxin \u03b2 locus and primary sjogren's syndrome in Scandinavian samples","volume":"71","author":"Bolstad","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jtos.2025.07.009_bib18","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00296-019-04354-0","article-title":"Fatigue in primary sj\u00f6gren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study","volume":"39","author":"Davies","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jtos.2025.07.009_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2020.03.013","article-title":"Evaluation of tear protein markers in dry eye disease with different lymphotoxin-alpha expression levels","volume":"217","author":"Chen","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.jtos.2025.07.009_bib21","first-page":"968","article-title":"Chinese expert consensus on the diagnosis and treatment of dry eye (2024)]","volume":"60","year":"2024","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease index and the symptom assessment in dry eye","volume":"122","author":"Amparo","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2025.07.009_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/ICL.0000000000000706","article-title":"Simplified classification of tear film Break-Up patterns and their clinicopathological correlations in patients with dry eye disease","volume":"47","author":"Eom","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib24","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0161-6420(92)31947-5","article-title":"Comparison of fluorescein and rose bengal staining","volume":"99","author":"Feenstra","year":"1992","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2025.07.009_bib26","first-page":"103","article-title":"Tear lysozyme in sjogren's syndrome, Meibomian gland dysfunction, and non-dry-eye","volume":"85","author":"Berra","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.07.009_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-198801000-00012","article-title":"Impression cytology","volume":"7","author":"Nelson","year":"1988","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2025.07.009_bib28","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1167\/iovs.11-9054","article-title":"Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease","volume":"53","author":"Huang","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2025.07.009_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0004563217695843","article-title":"Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis","volume":"54","author":"Rentka","year":"2017","journal-title":"Ann Clin Biochem"},{"issue":"10","key":"10.1016\/j.jtos.2025.07.009_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.12.10.19","article-title":"Investigation of conjunctival goblet cell and tear MUC5AC protein in patients with graves' ophthalmopathy","volume":"12","author":"You","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/ICO.0b013e3182801622","article-title":"Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye","volume":"32","author":"Zhang","year":"2013","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2025.07.009_bib32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","article-title":"Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial","volume":"119","author":"Matsumoto","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2025.07.009_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12325-019-01188-x","article-title":"Long-term safety and effectiveness of diquafosol for the treatment of dry eye in a real-world setting: a prospective observational study","volume":"37","author":"Ohashi","year":"2020","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jtos.2025.07.009_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The matrix metalloproteinase 9 point-of-care test in dry eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.jtos.2025.07.009_bib35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","article-title":"Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay","volume":"123","author":"Messmer","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.64.3.34","article-title":"IFN-\u03b3 facilitates corneal epithelial cell pyroptosis through the JAK2\/STAT1 pathway in dry eye","volume":"64","author":"Yang","year":"2023","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2025.07.009_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093111","article-title":"Dry eye disease and tear cytokine Levels-A meta-analysis","volume":"21","author":"Roda","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.07.009_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","article-title":"Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye","volume":"131","author":"Sambursky","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.07.009_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","article-title":"Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye","volume":"131","author":"Sambursky","year":"2013","journal-title":"Jama Ophthalmology"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071398","article-title":"Dry eye management: targeting the ocular surface microenvironment","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.07.009_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease: a review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur J Pharmaceut Sci"},{"issue":"11","key":"10.1016\/j.jtos.2025.07.009_bib42","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00417-018-4065-y","article-title":"Conjunctival MUC5AC+goblet cell index: relationship with corneal nerves and dry eye","volume":"256","author":"Chao","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2025.07.009_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.preteyeres.2018.11.007","article-title":"Reconsidering the central role of mucins in dry eye and ocular surface diseases","volume":"71","author":"Baudouin","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2025.07.009_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exer.2017.03.006","article-title":"The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE","volume":"167","author":"Soria","year":"2018","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2025.07.009_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3341\/jkos.2015.56.3.339","article-title":"Clinical efficacy of topical 3% diquafosol tetrasodium in short tear film Break-Up time dry eye","volume":"56","author":"Jung","year":"2015","journal-title":"J Korean Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2025.07.009_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jtos.2020.10.003","article-title":"Matrix metalloproteinase 9 positivity predicts long term decreased tear production","volume":"19","author":"Soifer","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.07.009_bib47","first-page":"243","article-title":"Quantification of a panel for dry-eye protein biomarkers in tears: a comparative pilot study using standard ELISA and customized microarrays","volume":"27","author":"Manuel Benitez-del-Castillo","year":"2021","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.jtos.2025.07.009_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/mi.2009.21","article-title":"Role of Th17 cells in the immunopathogenesis of dry eye disease","volume":"2","author":"Chauhan","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.jtos.2025.07.009_bib49","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.1984","article-title":"Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease","volume":"15","author":"Chiang","year":"2009","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jtos.2025.07.009_bib50","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1167\/iovs.15-17627","article-title":"Aqueous tear deficiency increases conjunctival Interferon-\u03b3 (IFN-\u03b3) expression and goblet cell loss","volume":"56","author":"Pflugfelder","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2025.07.009_bib51","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)63262-2","article-title":"Distinct roles for Lymphotoxin-\u03b1 and tumor necrosis factor in the control of Leishmania donovani infection","volume":"165","author":"Engwerda","year":"2005","journal-title":"Am J Pathol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:36:45Z","timestamp":1772890605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S1542012425000977"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.07.009","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tear lymphotoxin-alpha deficiency is associated with conjunctival epitheliopathy in patients with dry eye disease","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}